We have isolated four
insulin-like growth factor binding proteins (IGFBPs) from adult human serum by
insulin-like growth factor (
IGF) I affinity chromatography and high performance liquid chromatography. A 36-kDa
binding protein (BP), not digestible with
N-glycanase, is increased in patients with extrapancreatic
tumor hypoglycemia and during
IGF I administration in healthy adults. Its 38 NH2-terminal
amino acids are identical to those of an
IGFBP sequence derived from a human
cDNA that cross-hybridizes with the rat
IGFBP-2 cDNA. With probes encoding a NH2-terminal, COOH-terminal, and a middle region of this
protein we have obtained three
cDNA clones from a Hep G2 cDNA library; one encodes human
IGFBP-2, and the other two presumably represent unspliced heteronuclear and alternatively spliced
mRNA, respectively. A 28-30-kDa
IGFBP represents a novel BP species in human serum. Its 30 NH2-terminal
amino acids are not homologous to
IGFBP-1, -2, or -3. It is not digestible with
N-glycanase and does not bind 125I-IGF I. The NH2-terminal sequences of a 42/45- and a 31-kDa
IGFBP are identical to that of human
IGFBP-3. The 42/45-kDa
proteins are two glycosylation variants of BP-3. The 31-kDa
protein presumably is a degradation product of BP-3 that lacks the COOH terminus. It is likely that the different IGFBPs modulate auto-/paracrine and endocrine effects of IGFs on growth and metabolism in a different and specific manner.